机译:近视近视近期阿托品的两年临床试验(灯)研究阶段2报告
Chinese Univ Hong Kong Dept Ophthalmol &
Visual Sci Hong Kong Peoples R China;
Chinese Univ Hong Kong Dept Ophthalmol &
Visual Sci Hong Kong Peoples R China;
Chinese Univ Hong Kong Dept Ophthalmol &
Visual Sci Hong Kong Peoples R China;
Chinese Univ Hong Kong Dept Ophthalmol &
Visual Sci Hong Kong Peoples R China;
Chinese Univ Hong Kong Jockey Club Sch Publ Hlth &
Primary Care Hong Kong Peoples R China;
Chinese Univ Hong Kong Dept Ophthalmol &
Visual Sci Hong Kong Peoples R China;
Tung Wah Eastern Hosp Dept Ophthalmol Hong Kong Peoples R China;
Chinese Univ Hong Kong Dept Ophthalmol &
Visual Sci Hong Kong Peoples R China;
Chinese Univ Hong Kong Dept Ophthalmol &
Visual Sci Hong Kong Peoples R China;
Chinese Univ Hong Kong Dept Ophthalmol &
Visual Sci Hong Kong Peoples R China;
Chinese Univ Hong Kong Dept Ophthalmol &
Visual Sci Hong Kong Peoples R China;
机译:近视近视的低浓度阿托品(灯)研究近视控制中的随机,双盲,安慰剂对照试验0.05%,0.025%和0.01%的阿托品滴眼液
机译:近视近视的低浓度阿托品(灯)研究阶段2:0.05%阿托品在2年内,0.05%,0.025%和0.01%阿巴罗的最佳浓度
机译:0.05%,0.025%和0.01%的阿托嘌呤眼滴在角膜参数上滴眼液:近视进展的低浓度阿托品(灯)研究
机译:通过基于Web的平台在减肥试验中收集的自我报告重量的准确性:POEMAS临床试验的验证研究
机译:外用眼用阿托品对近视远期进展的影响。
机译:I / II阶段临床试验以评估白藜芦醇的疗效以防止对Covid19影响的血液学患者呼吸压力不全进展:随机对照试验的研究方案的结构化概述
机译:对近视进展的低浓度阿托品的两年临床试验(灯)研究
机译:协调中心模型项目:多中心临床试验中的协调中心研究。 VI。多中心临床试验的阶段